Safety of Treatment of Shoulder Repair

Rotator Cuff Clinical Trial

— HEALICOIL_KNTL  

Official title:

Prospective, Multi-Center, Post-Market Clinical Follow-up Study to Evaluate Safety and Performance of the HEALICOIL™ Knotless Suture Anchor in Shoulder Rotator Cuff Tendon Repair

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04552119
• Other study ID #: HEALICOIL.KNOTLESS.2019.12
• Status: Active, not recruiting
• Start date: December 30, 2020
• Est. completion date: December 31, 2024

Study information

• Verified date: April 2024
• Source: Smith & Nephew, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the safety of the HEALICOIL Knotless Suture Anchors in patients requiring a repair of the rotator cuff tendon repair

Description:

This is a multicenter, prospective, post-marketing, observational, case series study to evaluate the safety and efficacy of the HEALICOIL Knotless Suture Anchors in subjects with rotator cuff tendon repair. Approximately 160 subjects will be enrolled at up to 6 sites. Safety monitoring will include documentation device- and surgery-related AEs. Efficacy will be monitored by assessment of post-operative follow up, clinical complications, reoperation rate, EQ-5D-5L, and pain VAS.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 160
• Est. completion date: December 31, 2024
• Est. primary completion date: August 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Requires reattachment of soft tissue to bone for the following shoulder indications:

1. Rotator Cuff Tendon repair

• i. Single or double row rotator cuff repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping; OR
• ii. Double row rotator cuff repair using HEALICOIL Knotless RG NST in lateral row (existing HEALICOIL RG device to be used in medial row of the repair); AND/OR

2. Biceps tenodesis

• i. In conjunction with Rotator Cuff Tendon repair using HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, HEALICOIL Knotless RG NST or HEALICOIL Knotless RG Self-Tapping OR
• ii. As a stand-alone procedure for HEALICOIL Knotless PEEK NST, HEALICOIL Knotless PEEK Self-Tapping, or HEALICOIL Knotless RG Self-Tapping (not HEALICOIL Knotless RG NST

2. Has a pre-operative standard of care MRI within 6 months of surgery containing the

following sequences:

1. Sat T2 FS: Oblique Sag T2-weighted Fat Saturation Spin Echo (oriented perpendicular to the scapula), with TE > 70 ms, AND

2. Cor T2 FS: Oblique Cor T2-weighted Fat Saturation Spin Echo (oriented parallel to the scapula), with TE > 70 ms, AND

3. Sag T1: Oblique Sag T1-weighted Spin Echo (oriented perpendicular to the scapula); OR

4. Willing and able to undergo an additional study specific pre-operative MRI according to the study Imaging Protocol if the above criteria is not met OR

5. MRI not required; subject not in HEALICOIL RG NST subgroup

3. Has consented to participate in the study by signing the IRB/IEC approved informed consent form.

4. Requires only one variant of the HEALICOIL Knotless Suture Anchor

5. Is =18 years of age at time of surgery

6. Willing and able to make all required study visits

7. Able to follow instructions (Approved translated documents supplied upon request)

Exclusion Criteria:

• Any one (1) of the following criteria will disqualify a potential subject from

participation in the study:

1. Known hypersensitivity to the implant material. Where material sensitivity is suspected, appropriate tests should be made and sensitivity ruled out prior to implantation.

2. Pathological conditions of bone, such as cystic changes or severe osteopenia, which would compromise secure anchor fixation.

3. Pathological conditions in the soft tissues to be attached that would impair secure fixation by suture.

4. Comminuted bone surface, which would compromise secure anchor fixation.

5. Physical conditions which would eliminate, or tend to eliminate, adequate anchor support or retard healing

6. The presence of infection.

7. Conditions which would limit the subject's ability or willingness to restrict activities or follow directions during the healing period.

8. Concurrent bilateral surgery.

9. Participation in the treatment period of another clinical trial within thirty (30) days of Visit 1, or during the study.

10. Women who are pregnant.

11. Prior ipsilateral surgeries performed on the joint space.

12. Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Related Conditions & MeSH terms

• Rotator Cuff

Intervention

Device:
• HEALICOIL Knotless PEEK
HEALICOIL Knotless PEEK Self-Tapping HEALICOIL Knotless Non-Self Tapping
• HEALICOIL Knotless REGENESORB
HEALICOIL Knotless REGENESORB Self -Tapping HEALICOIL Knotless REGENSORB Non-Self Tapping

Locations

Country	Name	City	State
United States	University Orthopedics Center	Altoona	Pennsylvania
United States	Orthopaedic and Spine Center of Southern Colorado	Colorado Springs	Colorado
United States	University of Colorado - Denver	Denver	Colorado
United States	University of Stanford	Redwood City	California
United States	OrthoIllinois LTD	Rockford	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Smith & Nephew, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Repair failure rate of HEALICOIL Knotless Suture Anchors	Repair failure rate defined as the need for a second repair procedure at 6 months.	6 months
Secondary	Repair failure rate at 12 months and 24 months	Repair failure rate is defined as the need for a second repair procedure. Repair rate at 24 months will be collected for the HEALICOIL Knotless REGENESORB Non-Self Tapping subgroup only.	12 and 24 months
Secondary	Constant-Murley Score	Constant-Murley Shoulder (CMS) scale assesses four aspects related to shoulder pathology; two subjective: pain and activities of daily living (ADL) and two objective: range of motion (ROM) and strength. The subjective components can receive up to 35 points and the objective 65, resulting in a possible maximum total score of 100 points (best function). Pain and ADL are answered by the subject; ROM and strength require a physical evaluation and are answered by the orthopaedic surgeon or the physiotherapist.	6, 12, and 24 months
Secondary	American Shoulder and Elbow Surgeons (ASES) Visual Analog Scale (VAS) pain score	The ASES instrument is composed of 2 sections containing participant self-reported and clinician assessments. The ASES score is a 0 to 100-point rating with a higher score indicating improvement in pain and function. It is based solely on participant responses and is a combination of the participant's shoulder pain rating (VAS Pain) and self-reported ability to perform 10 different activities of daily living (ADLs).	6, 12, and 24 months
Secondary	Single Assessment Numeric Evaluation (SANE) Shoulder scale at 6 months and 12 months	The SANE is a simple, single-question, patient-based shoulder function assessment tool: ''How would you rate your shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?''	6 and 12 months
Secondary	EQ-5D-3L at 6 months and 12 months	The EuroQol EQ-5D-3L is a descriptive system measuring health-related Quality Of Life (QOL) and consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) each of which takes one of three responses. The responses record three levels of severity (no problems/some or moderate problems/extreme problems) within a particular EQ-5D-3L dimension.	6 and 12 months
Secondary	Tendon thickening and anchor absorption/replacement by bone at 6 months and 24 months for HEALICOIL Knotless REGENESORB Non-Self Tapping	Magnetic Resonance Imaging (MRI) will be used to determine tendon thickening and anchor absorption/replacement by bone at 6 and 24 months.	6 and 24 months
Secondary	Tendon re-tear rate at 6 months and 24 months for HEALICOIL Knotless REGENESORB Non-Self Tapping only	Magnetic Resonance Imaging (MRI) will be used to determine tendon re-tear rate at 6 months and 24 months.	6 and 24 months